Home > Search Results
  • We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 1 to 20 of 275

Efficacy and safety of shen song yang xin capsule for cardiac arrhythmia: a systematic review

Bibliographic details: Hu H, Tang HQ, Li JH, Yang LL, Tang WJ, Zhou ZR.  Efficacy and safety of shen song yang xin capsule for cardiac arrhythmia: a systematic review. Chinese Journal of Evidence-Based Medicine 2011; 11(2): 168-173 Available from: http://www.cjebm.org.cn/oa/DArticle.aspx?type=view&id=201102010

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet] - Centre for Reviews and Dissemination (UK).

Version: 2011

Efficacy of diagnostic tools for detecting cardiac arrhythmias: systematic literature search

BACKGROUND/OBJECTIVES: Symptoms suggestive of cardiac arrhythmias are a challenge to the diagnosis. Physical examination and a 12-lead ECG are of limited value, as rhythm disturbances are frequently of a paroxysmal nature. New technologies facilitate a more accurate diagnosis. The objective of this study was to review the medical literature in an effort to define a guide to rational diagnostic testing.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet] - Centre for Reviews and Dissemination (UK).

Version: 2010

Amiodarone prophylaxis reduces major cardiovascular morbidity and length of stay after cardiac surgery: a meta-analysis

The authors assessed the use of prophylactic amiodarone given around the time of cardiac surgery. They found that the incidence of atrial fibrillation or flutter, ventricular tachycardia or fibrillation, and stroke were reduced by amiodarone. Length of hospital stay was also reduced, but there was no difference in death rates. The review was well conducted and the results appear reliable.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet] - Centre for Reviews and Dissemination (UK).

Version: 2005

Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: a systematic review and meta-analysis

The authors concluded that women enrolled in primary prevention implantable cardioverter-defibrillator (ICD) trials had the same mortality as men while experiencing significantly less appropriate ICD intervention. Evidence appeared to support the authors? conclusions, but lack of reporting of review methods and study quality made it difficult to assess the reliability.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet] - Centre for Reviews and Dissemination (UK).

Version: 2010

Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized controlled trials

This review investigated the effectiveness of implantable cardioverter defibrillators (ICDs) in patients with increased risk of sudden cardiac death. The authors concluded that ICDs are more beneficial than drug therapy for secondary prevention of sudden cardiac death and for primary prevention in certain high-risk groups. The conclusions are likely to be reliable.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet] - Centre for Reviews and Dissemination (UK).

Version: 2003

Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: a meta-analysis

This review examined the effect of alpha-2-adrenergic antagonists on deaths and cardiovascular complications in patients having surgery. The authors concluded that alpha-2-adrenergic antagonists reduce deaths and heart attacks in patients having vascular surgery. They also concluded that these drugs reduce ischaemia during cardiac surgery. This was a reasonably well-conducted review and the conclusions are probably reliable.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet] - Centre for Reviews and Dissemination (UK).

Version: 2003

Surgical Maze procedure as a treatment for atrial fibrillation: a meta-analysis of randomized controlled trials

This review concluded that surgical Maze procedures were associated with a decrease in atrial fibrillation within 12 months of surgery without an increase in length of hospital stay, perioperative complications or mortality in patients with atrial fibrillation.The possibility of publication bias and lack of information on the quality of included trials creates some uncertainty about the robustness of the authors' conclusions.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet] - Centre for Reviews and Dissemination (UK).

Version: 2010

Long-term outcomes after the atrial switch for surgical correction of transposition: a meta-analysis comparing the Mustard and Senning procedures

The authors concluded that the results were not consistent across all outcomes for patients who had undergone Mustard and Senning procedures. Despite limitations to this review, the authors' cautious conclusions appear to reflect limited data from potentially biased observational studies.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet] - Centre for Reviews and Dissemination (UK).

Version: 2004

Loop Recorders to Detect Atrial Arrhythmias in Patients Post-discharge who have had a Cryptogenic Stroke: A Review of Clinical and Cost-effectiveness [Internet]

The purpose of this report is to examine the clinical effectiveness, safety and cost-effectiveness of loop recorders (external and implantable types) for the detection of atrial fibrillation (AF) in patients who have suffered a stroke of unknown origin (a ‘cryptogenic stroke’).

Rapid Response Report: Summary with Critical Appraisal - Canadian Agency for Drugs and Technologies in Health.

Version: March 25, 2014
Show search results within this document

Do omega-3 polyunsaturated fatty acids reduce risk of sudden cardiac death and ventricular arrhythmias? A meta-analysis of randomized trials

INTRODUCTION: Omega-3 polyunsaturated fatty acids (PUFA) have demonstrated to have antiarrhythmic properties. However, randomized studies have shown inconsistent results.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet] - Centre for Reviews and Dissemination (UK).

Version: 2013

Anti-arrhythmia drugs for cardiac arrest: a systemic review and meta-analysis

INTRODUCTION: Antiarrhythmia agents have been used in the treatment of cardiac arrest, and we aimed to review the relevant clinical controlled trials to assess the effects of antiarrhythmics during cardiopulmonary resuscitation.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet] - Centre for Reviews and Dissemination (UK).

Version: 2013

Effect of fish oil on arrhythmias and mortality: systematic review

This review investigated the effects of fish oil on mortality and arrhythmias. The authors found that fish oil supplementation was associated with a significant reduction in deaths from cardiac causes but was not beneficial for arrhythmic events or all-cause mortality. The authors' conclusions reflected the results but the reliability of these is unclear given heterogeneity between studies and unclear reporting.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet] - Centre for Reviews and Dissemination (UK).

Version: 2008

Magnesium prophylaxis for arrhythmias after cardiac surgery: a meta-analysis of randomized controlled trials

The authors of this review found that prophylactic magnesium given around the time of cardiac surgery reduced the incidence of cardiac arrhythmias, but had no effect on length of hospital stay or mortality. Given the potential for publication and selection bias, and the pooling of diverse results, the conclusions should be treated with caution.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet] - Centre for Reviews and Dissemination (UK).

Version: 2004

Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation

BACKGROUND: This assessment updates and expands on two previous technology assessments that evaluated implantable cardioverter defibrillators (ICDs) for arrhythmias and cardiac resynchronisation therapy (CRT) for heart failure (HF).

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet] - Centre for Reviews and Dissemination (UK).

Version: 2014

Chest Pain of Recent Onset: Assessment and Diagnosis of Recent Onset Chest Pain or Discomfort of Suspected Cardiac Origin [Internet]

Chest pain or discomfort caused by acute coronary syndromes (ACS) or angina has a potentially poor prognosis, emphasising the importance of prompt and accurate diagnosis. Treatments are available to improve symptoms and prolong life, hence the need for this guideline.

NICE Clinical Guidelines - National Clinical Guideline Centre for Acute and Chronic Conditions (UK).

Version: March 2010
Show search results within this document

Systematic Review of Decision Tools and Their Suitability for Patient-Centered Decisionmaking Regarding Electronic Cardiac Devices [Internet]

1) Identify validated decision aids available for insertion, continuation, or deactivation of electronic cardiac devices (ECDs); 2) Review evidence on the effectiveness of decision aids for promoting informed decisionmaking and their relevance to the Medicare population; 3) Identify barriers to use of decision aids.

Technology Assessment Report - Agency for Healthcare Research and Quality (US).

Version: May 23, 2012
Show search results within this document

Assessment on Implantable Defibrillators and the Evidence for Primary Prevention of Sudden Cardiac Death [Internet]

Implantable cardioverter–defibrillators (ICDs) are battery-powered implantable devices that monitor heart rhythm and deliver therapy in the form of either electric shock or antitachycardia pacing (ATP) when a life-threatening ventricular arrhythmia is detected. ICDs have been used in patients who survived sustained ventricular arrhythmias to prevent sudden cardiac death (SCD). In recent years, ICDs have also been implanted for primary prevention (prevention of SCD in a patient who has not had yet had sustained ventricular tachyarrhythmia but has risk factors for it). ICDs may also include cardiac resynchronization therapy (CRT) for additional treatment of heart failure in patients with dyssynchronous ventricles.

Technology Assessment Report - Agency for Healthcare Research and Quality (US).

Version: June 26, 2013
Show search results within this document

Corticosteroid therapy for cardiac sarcoidosis: a systematic review

BACKGROUND: There are no published clinical consensus guidelines or systematic evaluation supporting the use of corticosteroids for the treatment of cardiac sarcoidosis. The purpose of this study was to systematically review the published data on corticosteroid treatment of cardiac sarcoidosis.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet] - Centre for Reviews and Dissemination (UK).

Version: 2013

Meta-analysis of thoracic epidural anesthesia versus general anesthesia for cardiac surgery

The review found that thoracic epidural analgesia with general anaesthesia in patients who underwent cardiac surgery reduced supraventricular arrhythmia and respiratory complications. The effects on mortality, myocardial infarction and stroke were uncertain. These conclusions appear reliable in most respects but the findings about supraventricular arrhythmia should be interpreted with caution due to heterogeneity between the studies and possible bias.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet] - Centre for Reviews and Dissemination (UK).

Version: 2011

Use of ECG to prevent cardiac risk in opioid dependents treated with methadone

No evidence has been found to support the use of the electrocardiogram (ECG) for preventing cardiac arrhythmias in methadone‐treated opioid dependents. A maintenance program with methadone is an effective treatment for people who are dependent on opioids, in terms of increased retention in treatment, reduced use of opioids, reduced human immunodeficiency virus (HIV) transmission and reduced mortality. Nowadays methadone represents the most frequently used medication for this disorder. However, the use of methadone has been associated with a potentially fatal cardiac arrhythmia called torsade de pointes (TdP). Evidence supporting the relationship between methadone and TdP is limited. However, given the risk involved for the life of patients, consensus and recommendations for patients receiving methadone treatment have been developed. Recommended procedures aim to identify patients who present a specific alteration of the ECG, represented by prolongation of the QT interval, which is considered a marker for arrhythmias such as TdP. Patients identified as at risk may then be provided with alternative treatment (reduction of methadone dosage; provision of alternative opioid agonist treatment; treatment of associated risk factors). However, the acceptability of ECG screening has been questioned because the procedures involved may be too demanding and stressful, may interfere with the availability of patients to undergo methadone maintenance and may expose patients to health consequences of untreated opioid addiction, including increased mortality risk. This review looked at the evidence on the efficacy and acceptability of such ECG‐based screening procedures. Even though the search was extended to different experimental and non‐ experimental study designs, the authors did not find any study that fulfilled methodological criteria for the review. Therefore, it is not possible to draw any conclusions about the effectiveness of ECG‐based screening strategies for preventing cardiac morbidity/mortality in methadone‐treated opioid addicts. Research efforts should focus on strengthening the evidence about the effectiveness of widespread implementation of such strategies and clarifying associated benefits and harms.

Cochrane Database of Systematic Reviews: Plain Language Summaries [Internet] - John Wiley & Sons, Ltd.

Version: 2013

Medical Encyclopedia

  • Arrhythmias
    An arrhythmia is a disorder of the heart rate (pulse) or heart rhythm. The heart can beat too fast (tachycardia), too slow (bradycardia), or irregularly.
  • Arrhythmia
    An arrhythmia is a problem with the rate or rhythm of the heartbeat. During an arrhythmia, the heart can beat too fast, too slow, or with an irregular rhythm.
  • Sudden Cardiac Arrest
    Sudden cardiac arrest (SCA) is a condition in which the heart suddenly and unexpectedly stops beating. SCA usually causes death if it's not treated within minutes.
See all (85)...

Systematic Reviews in PubMed

See all (2440)...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...